MedTrace Logo

A Study to Evaluate the Impact of Using Warm Compress Prior to Daily Injections of Copaxone®

NCT00239993 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2017-02-06

No results posted yet for this study

Summary

This study is designed to compare skin reactions with or without the use of warm compress prior to performing a Copaxone® injection.

Conditions

Interventions

DRUG

glatiramer acetate

PROCEDURE

Warm compress prior to injection of glatiramer acetate

Sponsors & Collaborators

  • Teva Neuroscience, Inc.

    lead INDUSTRY

Principal Investigators

  • MerriKay Oleen-Burkey, Ph.D · Teva Neuroscience, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-08-31
Primary Completion
2005-12-31
Completion
2006-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00239993 on ClinicalTrials.gov